Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

LITS Relative to the S&P 500

LITS Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Lite Strategy Inc. (NASD:LITS) seasonal charts above shows that a Buy Date of July 2 and a Sell Date of September 21 has resulted in a geometric average return of 2.84% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 102.84% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Lite Strategy, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.

To download LITS seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: LITS